MARKET

DERM

DERM

Journey Medical Corp
NASDAQ
4.575
-0.205
-4.29%
After Hours: 4.774 +0.199 +4.36% 19:15 03/27 EDT
OPEN
4.850
PREV CLOSE
4.780
HIGH
4.940
LOW
4.510
VOLUME
665.77K
TURNOVER
--
52 WEEK HIGH
9.56
52 WEEK LOW
4.510
MARKET CAP
152.15M
P/E (TTM)
-12.5514
1D
5D
1M
3M
1Y
5Y
1D
Journey Medical Rides Emrosi Surge Toward Profitability
TipRanks · 1d ago
Journey Medical (DERM) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
NASDAQ · 1d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 1d ago
Journey Medical Corp (DERM) Gets a Buy from Alliance Global Partners
TipRanks · 2d ago
Journey Medical price target raised to $12 from $11 at B. Riley
TipRanks · 2d ago
Analysts Offer Insights on Healthcare Companies: Journey Medical Corp (DERM), Quoin Pharmaceuticals (QNRX) and SeaStar Medical Holding (ICU)
TipRanks · 2d ago
Journey Medical Price Target Maintained With a $13.00/Share by HC Wainwright & Co.
Dow Jones · 2d ago
HC Wainwright & Co. Reiterates Buy on Journey Medical, Maintains $13 Price Target
Benzinga · 2d ago
More
About DERM
Journey Medical Corporation is a commercial-stage pharmaceutical company. The Company is focused on selling and marketing of the United States Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the United States. Its marketed products, which have been approved FDA for sale in the United States, include Qbrexza, Accutane, Amzeeq, Zilxi, Exelderm Cream and Solution, Targadox, and Luxamend. Qbrexza is a medicated cloth towelette for the treatment of primary axillary hyperhidrosis. Accutane is an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne. Targadox is an oral doxycycline drug for adjunctive therapy for severe acne. Luxamend is a water-based emulsion formulated to provide moist healing environment.

Webull offers Journey Medical Corp stock information, including NASDAQ: DERM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DERM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DERM stock methods without spending real money on the virtual paper trading platform.